Prosthetic Joint Infection Treatment Market

Primary treatment options for PJI include surgical intervention such as debridement, antibiotics, and implant retention (DAIR), one-stage and two-stage revision surgeries, and long-term antibiotic therapy.

The global prosthetic joint infection treatment market is anticipated to witness significant growth due to rising incidences of joint replacement surgeries, advancements in medical technology, and increasing awareness about the importance of infection prevention in orthopedic procedures.

Key challenges include the emergence of antibiotic-resistant strains, the risk of treatment failure and recurrence, limited availability of effective antimicrobial agents, and the high cost associated with prolonged treatment and revision surgeries.

Healthcare policies and regulations can significantly influence the adoption of treatment protocols, reimbursement policies for surgical procedures and antibiotic therapies, and the development and commercialization of new medical devices and antimicrobial agents for PJI treatment.

Current trends include the development of novel antimicrobial coatings for orthopedic implants, the use of advanced diagnostic techniques such as molecular testing and imaging modalities, and the exploration of alternative treatment strategies such as phage therapy and immunomodulation to combat PJI.